SC-435 | m-entrepreneurship.com

Product Name :
SC-435

Search keywords :
SC-435

drugId :
null

Target Vo:
Ileal bile acid transporter

Target Vo Short Name :
IBAT

Moa_Name:
Ileal bile acid transporter inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Connecticut

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tralokinumab Interleukin Related
Nirsevimab supplier
RBPJK Antibody: RBPJK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to RBPJK. It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts